Aktuelle investeringer
266 Investeringer
| Titel | Periode Sortér faldende | Program | |
|---|---|---|---|
| MicroBIOlogically assisted MApping of soil Pollution BIOMAP | 2019 - 2022 | Grand Solutions
|
|
|
MicroBIOlogically assisted MApping of soil Pollution BIOMAP
Periode
2019 - 2022
Region
Program
Grand Solutions Fagområde
Bioressourcer, Fødevarer og Livsstil Investering
Percentage
70.18 Fondens investering
11,6 mio. Samlet budget
16,5 mio. BIOMAP will develop and bring to market a technique for soil pollution mapping that can save a large part of the spending on pollution mapping which for the Danish society alone is approx. €27 mill. yearly. With this technique, a site can be mapped at a cost several times less compared to conventional drilling and much faster. The proven scientific basis for the technique is electric currents created by microorganisms that degrade pollution. Pilot investigations have been promising. In BIOMAP we will make a thorough verification and development of "Biomapping" in a range of site types and conditions. The final goal of BIOMAP is to commercialize pollution mapping services and instruments.
Projektdeltagere
Aarhus University (Bioscience), Aarhus University (Geoscience), Dansk Mijørådgivning A/S, Region Midtjylland/Central Denmark Region (Environment), Region Hovedstaden/Captial Region of Denmark (Center for Regional Udvikling, Miljøenheden) Projektleder
Aktiv
Læs mere om projektet
| |||
| Centre for faecal microbiota transplantation at Aarhus University Hospital (CEFTA) | 2019 - 2024 | Grand Solutions
|
|
|
Centre for faecal microbiota transplantation at Aarhus University Hospital (CEFTA)
Periode
2019 - 2024
Region
Program
Grand Solutions Fagområde
Biotek, Medico og Sundhed Investering
Percentage
69.91 Fondens investering
17,1 mio. Samlet budget
24,5 mio. What is the innovation and the need behind the innovation?:
Faecal microbiota transplantation (FMT) is a pioneering therapeutic option used for treating acute and chronic diseases associated with a dysregulated intestinal microbiota.;
What is the most important competing solution?:
Three equally important competing solutions exists: Probiotics, antibiotics, and specific immune modulating drugs.;
Who will ultimately receive the value created?:
Patients in public health care, who suffer from antibiotic-associated diarrhoea caused by Clostridium difficile.;
What will the applied investment from Innovation Fund Denmark mainly be used for?:
Infrastructure and legal aspects; encapsulated application; clinical trials; analysis of microbiota and health economics.;
How will the project results be implemented?
In a sequence of four work packages, the generated results are anchored in a joined centre function for FMT at AUH (CEFTA).
Projektdeltagere
Aarhus University Hospital (Department of Hepatology and Gastroenterology), Aarhus University Hospital (Department of Clinical Immunology), Technical University of Denmark (DTU Food), Aalborg University (Department of Business and Management) Projektleder
Aktiv
Læs mere om projektet
| |||
| Ultra-Violet supercontinuumsources and pulsed lasers for thesemiconductor industry UVSUPER | 2019 - 2023 | Grand Solutions
|
|
|
Ultra-Violet supercontinuumsources and pulsed lasers for thesemiconductor industry UVSUPER
Periode
2019 - 2023
Region
Program
Grand Solutions Fagområde
Produktion, Materialer, Digitalisering og IKT Investering
Percentage
37.96 Fondens investering
10,0 mio. Samlet budget
26,3 mio. What is the innovation and the need behind the innovation?:Semiconductor industry needs shortest possible wavelength UV laser for inspection
-UV lasers @ <190nm do not exist
UVSUPER makes
-Tunable pulsed UV lasers @<160nm
-Broadband lasers @ 160-1000nm;
What is the most important competing solution?:
-Shortest single-wavelength ArF eximer laser @ 193nm
-Toucan frequency converter from Ultralumina covering 180-1600nm;
Who will ultimately receive the value created?:
NKT captures semiconductor OEMs
DFM increases UV characterization consultancy
DTU establishes fiber technology for spin-out;
What will the applied investment from Innovation Fund Denmark mainly be used for?:
Salary for 4 expert scientists, glove box for glass fabrication, UV
characterization equipment, ultra-sonic glass driller;
How will the project results be implemented?:
Partner NKT committed to market sources
End user semiconductor OEM contacted
End user DFM partner for direct evaluation
Projektdeltagere
Technical University of Denmark, NKT Photonics A/S, Danish Fundamental Metrology A/S Projektleder
Aktiv
Læs mere om projektet
| |||
| Fighting auditory hallucinations by simulation training in a Virtual Reality environment CHALLENGE | 2019 - 2023 | Grand Solutions
|
|
|
Fighting auditory hallucinations by simulation training in a Virtual Reality environment CHALLENGE
Periode
2019 - 2023
Region
Program
Grand Solutions Fagområde
Biotek, Medico og Sundhed Investering
Percentage
74.02 Fondens investering
13,3 mio. Samlet budget
18,0 mio. What is the innovation and the need behind the innovation?:Psychotic symptoms, especially hallucinations, are the hallmarks of schizophrenia. Simulation training in a virtual environment can improve coping strategies when facing these severe symptoms;
What is the most important competing solution?:
Antipsychotic medication and cognitive behavioural therapy are effective, but some patients have treatment resistant symptoms;
Who will ultimately receive the value created?:
Patients with schizophrenia who have stressful auditory hallucinations. The health care system and small Danish companies.;
What will the applied investment from Innovation Fund Denmark mainly be used for?:
Conduction of a randomized clinical trial evaluating AVATAR treatment, support from UK, salaries for trainers and evaluators.;
How will the project results be implemented?:
If the randomized clinical trial show positive results, the solutions will be implemented in psychiatric outpatient clinics.
Projektdeltagere
Mental Health Services in the Capital Region of Denmark (Region Hovedstadens Psykiatri) (Region Hovedstaden), Aalborg Universitetshospital, Khora ApS, Region Syddanmark, Lokalpsykiatri Esbjerg (Region Syddanmark) Projektleder
Aktiv
Læs mere om projektet
| |||
| ShippingLab - Driving Future Maritime Technology ShippingLab | 2019 - 2021 | Grand Solutions
|
|
|
ShippingLab - Driving Future Maritime Technology ShippingLab
Periode
2019 - 2021
Region
Program
Grand Solutions Fagområde
Produktion, Materialer, Digitalisering og IKT Investering
Percentage
37.58 Fondens investering
32,7 mio. Samlet budget
86,9 mio. What is the innovation and the need behind the innovation?:Secure Blue Denmark’s position in the forefront of the global market. Industry needs innovation and visionary showcases to remain competitive in the age of digitalisation and autonomy.;
What is the most important competing solution?:
Digital players with no operational know-how of shipping and sparse understanding of the robustness solutions at sea require.;
Who will ultimately receive the value created?:
Ship operators and technology suppliers, with ripple effects into society by cleaner and more efficient transport & logistics;
What will the applied investment from Innovation Fund Denmark mainly be used for?:
Research & development with Danish companies. Investment is necessary seed capital to leverage private co-financing.;
How will the project results be implemented?:
Suppliers will offer autonomy solutions for retrofit and newbuildings, digitalization services and decarbonization technology
Projektdeltagere
Technical University of Denmark, Automation Lab A/S, Ballard Power Systems Europe A/S, Copenhagen Business School (Strategy and Innovation), Callenberg A/S, Danelec Electronics A/S (R&D), Danfoss A/S - Salg Danmark (Salg Danmark, Danfoss Drives), Danske Færger A/S (Fleet Management), Danske Maritime (Technical), DFDS A/S (Technical Organization), FORCE Technology (Division for Maritime Industry), Udvikling Fyn (Fyns Maritime Cluster), J-Lauritzen A/S (LKFM), Logimatic Solutions A/S, Maersk Tankers A/S (Technical Operation), MAN Energy Solutions (former MAN Diesel and Turbo) (Supply Chain Management), Scandlines Danmark ApS (Rødby), Svendborg International Maritime Academy, Stigsborg Havnefront *MASH*
c/o Center For logistic og Samarbejde (Aalborg), Danish Technological Institut – DTI (C014 Transport and electrical systems), TORM A/S (Technical Division / Fleet Systems), TUCO YACHT VÆRFT ApS, Vessel Performance Solutions APS (do), Wartsila Lyngsø Marine A/S (New Building), Aalborg University (29102384), Unnamed Projektleder
Aktiv
Læs mere om projektet
| |||
| Human Milk Oligosaccharides EXpanded PORTfolio by novel enzymatic routes HMO-EXPORT | 2019 - 2022 | Grand Solutions
|
|
|
Human Milk Oligosaccharides EXpanded PORTfolio by novel enzymatic routes HMO-EXPORT
Periode
2019 - 2022
Region
Program
Grand Solutions Fagområde
Biotek, Medico og Sundhed Investering
Percentage
63.12 Fondens investering
7,1 mio. Samlet budget
11,3 mio. We want to improve infant formula to mimic breast milk more closely. Over 150 different human milk oligosaccharides (HMOs) exist. They are crucial for infant health and development, but absent from infant formula. Glycom A/S produces two HMOs industrially by fermentation, but alternative technologies are required to broaden the portfolio. This can be done by enzymatic transglycosylation, a technology refined at DTU Bioengineering. Our combined efforts create value in healthier formula-fed infants and expansion in Danish knowledge-based industry (>200 jobs). Estimated market value creation is 2bn euros/year. Glycom A/S are HMO production experts making result implementation straightforward.
Projektdeltagere
Glycom A/S, Technical University of Denmark (Danmarks Tekniske Universitet) Projektleder
Aktiv
Læs mere om projektet
| |||
| Innovative vaccines to prevent post-weaning diarrhoea in pigs Pig-Vac | 2019 - 2023 | Grand Solutions
|
|
|
Innovative vaccines to prevent post-weaning diarrhoea in pigs Pig-Vac
Periode
2019 - 2023
Region
Program
Grand Solutions Fagområde
Bioressourcer, Fødevarer og Livsstil Investering
Percentage
74.97 Fondens investering
11,0 mio. Samlet budget
14,7 mio. What is the innovation and the need behind the innovation?:The innovation is novel vaccines preventing post-weaning diarrhoea in pigs. This disease is costly in terms of production losses and is the main reason for use of antimicrobials in livestock in DK.;
What is the most important competing solution?:
There are vaccines on the market, but they are not sufficiently effective. Zink is used to prevent PWDnow, but is phased out.;
Who will ultimately receive the value created?:
Danish pig producers, AdaptVac, an SME vaccine company, and the society by lowered antimicrobial resistance.;
What will the applied investment from Innovation Fund Denmark mainly be used for?:
Development and testing of novel vaccines under experimental and field conditions (TRL7).;
How will the project results be implemented?:
AdaptVac sells licence to produce vaccine to world leading company with capacity to bring the novel vaccines to market.
Projektdeltagere
University of Copenhagen (Veterinary and Animal Sciences), University of Copenhagen (Department of Immunology and Microbiology), AdaptVac, seges (Danish Pig Research Centre) Projektleder
Aktiv
Læs mere om projektet
| |||
| Flexible Energy Denmark FED | 2019 - 2023 | Grand Solutions
|
|
|
Flexible Energy Denmark FED
Periode
2019 - 2023
Region
Program
Grand Solutions Fagområde
Produktion, Materialer, Digitalisering og IKT Investering
Percentage
73.69 Fondens investering
30,0 mio. Samlet budget
40,7 mio. What is the innovation and the need behind the innovation?:FED develops TOOLS and SOLUTIONS based on big data and AI to activate FLEXIBILITY at all levels of the energy systems enabling the green transition. The methods are tested in connected LIVING LABS.;
What is the most important competing solution?:
The main competing solutions are large-scale batteries and super-grids, both requiring significantly larger investments.;
Who will ultimately receive the value created?:
The companies, which faster develop better products using the FED digital infrastructure, and the Danish society at large.;
What will the applied investment from Innovation Fund Denmark mainly be used for?:
The investment funds a DATA LAKE, TOOLS, SOLUTIONS, tests at LIVING LABS and the FED FOUNDATION as a platform for companies.;
How will the project results be implemented?:
In specific SOLUTIONS developed in the project, and in further PRODUCTS and services at FED FOUNDATION companies.
Projektdeltagere
Technical University of Denmark (Compute), Technical University of Denmark (DTU Management Engineering), Aalborg University (Computer Science Daisy), Aalborg University (AAU CISS), Aarhus University (Department of Engineering), University of Southern Denmark, FlexShape Aps (Flexshape), Center Danmark A/S, Grundfos Holding A/S, Novasol A/S (Novasol), Neogrid Technologies ApS, Gate 21, EMD International A/S (EMD), Xtel Wireless ApS, Aalborg Energiforsyning, Albertslund Kommune, Høje Tåstrup Kommune, ENFOR, Eurisco, Tmrow IVS, ABB A/S, Green Tech Center A/S, TREFOR Infrastructure A/S, EWII A/S, Neas Energy A/S, Danfoss A/S Projektleder
Aktiv
Læs mere om projektet
| |||
| Mechanism Of Regenerative Cell Action (MORCA) MORCA MORCA | 2019 - 2024 | Grand Solutions
|
|
|
Mechanism Of Regenerative Cell Action (MORCA) MORCA MORCA
Periode
2019 - 2024
Region
Program
Grand Solutions Fagområde
Biotek, Medico og Sundhed Investering
Percentage
70.64 Fondens investering
5,0 mio. Samlet budget
7,1 mio. The regenerative capacity of stem cells including Adipose Derived Regenerative Cells (ADRCs) is widely accepted, however their mechanism of action (MoA) is not defined. We have identified a stromal cell population (CD31+ cells) that dose-dependently correlate with the clinical effect in erectile dysfunction and lymphedema trials. Using multiple in vitro and in vivo assays and phase I trials, we will test the hypothesis that CD31+ cells are likely to be the major player behind the regenerative effects of ADRCs by understanding the CD31+ cells and the host reaction to transplantation. We have formed a company, patented the CD31+ cells, and will test GMP grade CD31+ cells in phase I trials.
Projektdeltagere
Odense University Hospital, Charité - Universiitätsmedizin Berlin, Germany (Julius Wolff Institut) Projektleder
Aktiv
Læs mere om projektet
| |||
| Realizing high temperature electrolysis stacks for green ammonia production REFORGE | 2020 - 2023 | Grand Solutions
|
|
|
Realizing high temperature electrolysis stacks for green ammonia production REFORGE
Periode
2020 - 2023
Region
Program
Grand Solutions Fagområde
Bioressourcer, Fødevarer og Livsstil Investering
Percentage
73.21 Fondens investering
23,3 mio. Samlet budget
31,8 mio. H2 produced by renewable energy (RE) is already needed but costly. Haldor Topsoe has identified a stepping stone approach for a cost-effective introduction of electrolysis in so-called hybrid NH3 plants and other niche markets. Economic analysis shows that efficiency of the electrolysis plant is key for the total plant cost. SOEC is the most efficient electrolysis technology available, but the scale not ready for multi-MW plants.
The current project addresses this; making the SOEC technology scalable and with its superior efficiency make it the preferred electrolysis technology of the future. Systems will be designed in a parallel EUDP project and followed by a demo NH3 plant by 2025
Projektdeltagere
Haldor Topsoe A/S, Technical University of Denmark (Department of Energy Conversion and Storage) Projektleder
Aktiv
Læs mere om projektet
| |||
| Development of reliable and efficient alkaline membrane electrolyzers DREAME DREAME | 2020 - 2024 | Grand Solutions
|
|
|
Development of reliable and efficient alkaline membrane electrolyzers DREAME DREAME
Periode
2020 - 2024
Region
Program
Grand Solutions Fagområde
Bioressourcer, Fødevarer og Livsstil Investering
Percentage
74.81 Fondens investering
11,3 mio. Samlet budget
15,2 mio. An efficient, scalable and affordable electrolyzer technology is paramount in the green transition. The project will make that possible by developing a new electrolyte membrane that will enable the inexpensive alkaline electrolyzer to become as efficient at the best and very expensive PEM electrolyzers. This new generation technology will be manufactured without any noble or scares materials. It will thus be unlimited scalable and capable of meeting the huge demand for energy storage and conversion to fuel of a future sustainable energy system. The competitive technology will have a strong Danish business case and export potential.
Projektdeltagere
Technical University of Denmark (Departmen of Energy Conversion and Storage), Rensselaer Polytechnic Institute (Department of Chemistry and Chemical Biology), Green Hydrogen, Danish Power Systems Projektleder
Aktiv
Læs mere om projektet
| |||